Two large phase 3 trials found that oral semaglutide 14 mg did not slow cognitive or functional decline over 104 weeks in ...

Scientists may have sniffed out a breakthrough when detecting Alzheimer’s. The degenerative disease, which affects millions ...

The results of the EVOKE and EVOKE+ trials were comprehensive in showing oral semaglutide’s lack of clinical efficacy for ...

Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, finds the ...

Co-pathology may speed brain changes in women ...

A new Duke study is exploring whether cells inside the nose could reveal early signs of Alzheimer’s disease. Researchers say ...

A simple nasal swab may detect early Alzheimer’s disease changes before memory loss, offering a quick, non-invasive way to ...

Add Yahoo as a preferred source to see more of our stories on Google. In the latest research showing the benefits of staying active as you get older, exercise has been found to reduce the risk of ...

After decades of slow progress in understanding and developing effective treatments for Alzheimer’s disease, scientists are ...

Novel and potent catalytic approach that directly clears amyloid on the inside of neurons as well as reduces amyloid plaques with the potential to be superior to monoclonal antibodies and restore ...

A new study found that women who test positive for A Parkinson-s related protein accumulated tau at a much faster rate, indicating that it may act as an Alzheimer's disease accelerator.